A master’s student in Allergy at the University of Southampton is seeking volunteers aged 18 or over who have three or more confirmed food allergies from the UK’s top 14 major allergens….
Read more
Whether you’re a first-time school parent or preparing to send your little one off to “big school”, choosing the right setting can feel both exciting and overwhelming. For families of children with allergies, there’s the added challenge…
Read more
Last Wednesday (12 November), we were proud to host our second Business Symposium — an inspiring gathering of more than 140 professionals from the food industry and regulatory sectors. Held at The…
Read more
Following some recent queries, we’ve put together a few tips to help you check whether your Adrenaline Auto-Injectors (AAIs) need replacing. Adrenaline is the first-line treatment for serious allergic reactions (anaphylaxis). It…
Read more
Anaphylaxis UK announces that Simon Williams has stepped down from his role as Chief Executive to pursue other opportunities.
Read more
The National Allergy Strategy Group (NASG) – an alliance between professional organisation BSACI and patient charities including Anaphylaxis UK, Allergy UK, and the Natasha Allergy Research Foundation — is calling on the…
Read more
Anaphylaxis UK is delighted to announce a new partnership with the Out of School Alliance (OOSA) — a leading membership organisation supporting providers of wraparound care and holiday clubs across the UK….
Read more
Back in July, we welcomed the news that the UK medicines regulator (MHRA) had approved the country’s first needle-free adrenaline nasal spray, EURneffy® for people living with serious allergies. And in another positive step forward, EURneffy® is now available on prescription in the UK.
Read more
A new UK study led by Imperial College London, published in Archives of Disease in Childhood, finds that providing every school with spare adrenaline auto-injectors (AAIs) could improve emergency care for children and save…
Read more